MedTrace Logo

Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3

NCT00565396 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2007-11-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether fosinopril and losartan are effective in the treatment of patients with Chronic Kidney Disease(CKD) stage 3.

Conditions

  • Chronic Kidney Insufficiency
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin II Type 1 Receptor Blockers
  • Proteinuria

Interventions

DRUG

Fosinopril and Losartan

Fosinopril 10mg/day(oral) Losartan 50mg/day(oral)

Sponsors & Collaborators

  • Shanghai Municipal Health Bureau

    lead OTHER_GOV

Principal Investigators

  • Nan Chen, M.D. · Ruijin Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Completion
2008-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00565396 on ClinicalTrials.gov